The clinical usefulness of serum cartilage biomarkers and their diagnostic power in the evaluation of anti-TNF-α therapeutic response among RA patients was determined by assessing the area under the receiver operating characteristic curve (AUC). This evidence concerns the gene TNF and rheumatoid arthritis.